P
37.81
-1.10 (-2.83%)
| Previous Close | 38.91 |
| Open | 38.52 |
| Volume | 724,215 |
| Avg. Volume (3M) | 1,562,383 |
| Market Cap | 5,921,618,432 |
| Price / Earnings (TTM) | 36.01 |
| Price / Earnings (Forward) | 15.48 |
| Price / Sales | 0.990 |
| Price / Book | 5.55 |
| 52 Weeks Range | |
| Earnings Date | 7 Nov 2024 |
| Profit Margin | 2.59% |
| Operating Margin (TTM) | 0.07% |
| Diluted EPS (TTM) | 0.610 |
| Quarterly Revenue Growth (YOY) | 29.10% |
| Quarterly Earnings Growth (YOY) | 30.70% |
| Total Debt/Equity (MRQ) | 469.36% |
| Current Ratio (MRQ) | 1.71 |
| Operating Cash Flow (TTM) | 99.08 M |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Mixed |
| Medical Care Facilities (Global) | Bullish | Bullish | |
| Stock | PACS Group, Inc. | Bullish | Bullish |
AIStockmoo Score
0.2
| Analyst Consensus | 4.0 |
| Insider Activity | -3.0 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -0.5 |
| Average | 0.20 |
|
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Core |
| % Held by Insiders | 72.29% |
| % Held by Institutions | 29.86% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Defilade Capital Management, L.P. | 31 Dec 2025 | 1,145,485 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 52.00 (RBC Capital, 37.53%) | Buy |
| Median | 44.00 (16.37%) | |
| Low | 42.00 (Oppenheimer, 11.08%) | Buy |
| Average | 46.00 (21.66%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 36.40 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Oppenheimer | 04 Mar 2026 | 42.00 (11.08%) | Buy | 36.35 |
| UBS | 04 Mar 2026 | 44.00 (16.37%) | Buy | 36.35 |
| RBC Capital | 27 Feb 2026 | 52.00 (37.53%) | Buy | 36.51 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| JERGENSEN JOSHUA | - | 34.84 | -36,335 | -1,265,911 |
| Aggregate Net Quantity | -36,335 | |||
| Aggregate Net Value ($) | -1,265,911 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 34.84 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| JERGENSEN JOSHUA | Officer | 13 Mar 2026 | Sell (-) | 36,335 | 34.84 | 1,265,911 |
| Date | Type | Details |
|---|---|---|
| 20 Jan 2026 | Announcement | PACS Group Announces the Acquisition of Three Post-Acute Operations and the Real Estate of Four Facilities |
| 12 Jan 2026 | Announcement | PACS Group, Inc. to Present at Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2026, at 5:15 p.m., Pacific Time |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |